Literature DB >> 12079511

Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis.

Yutaka Midorikawa1, Shuichi Tsutsumi, Hirokazu Taniguchi, Masami Ishii, Yuko Kobune, Tatsuhiko Kodama, Masatoshi Makuuchi, Hiroyuki Aburatani.   

Abstract

To identify the genes associated with dedifferentiation of hepatocellular carcinoma (HCC), gene expression profiles of HCCs of well-and moderately differentiated grades were compared by means of oligonucleotide arrays. One tumor showed a nodule-in-nodule appearance (NIN), which is occasionally observed in the course of progression of HCC from well to less differentiated grade, when an inner, moderately differentiated tumor (MD) develops sequentially from the outer, well-differentiated tumor (WD). Seventy-six genes were identified to be up-regulated more than 3-fold and 33 genes were down-regulated in the inner nodule in NIN. By statistical analysis of the profiles from 10 individual additional liver tumors, 5 WDs and 5 MDs, we were able to identify 12 genes, LAMA3, PPIB, ADAR, PSMD4, NDUFS8, D9SVA, CCT3, GBAP, ARD1, RDBP, CSRP2, and TLE1, with significantly elevated expression, and 4 genes, CP, IL7R, CD48, and PLGL, with decreased expression in MD. These selected genes were further validated using another 12 tumors, 5 WDs and 7 MDs, with semi-quantitative RT-PCR. We also applied neighborhood analysis to list the genes with high predictability values as most closely correlated with WD-MD distinction. Seven genes, ADAR, PSMD4, D9SVA, CCT3, GBAP, RDBP, and CSRP2, whose expression was elevated and one gene, IL7R, whose expression was decreased, were included among the top 50 predictor genes. These genes are likely to be associated with dedifferentiation of HCC and their identification may help to elucidate the mechanism of liver cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079511      PMCID: PMC5927043          DOI: 10.1111/j.1349-7006.2002.tb01301.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellular carcinoma well‐differentiated hepatocellular carcinoma moderately differentiated hepatocellular carcinoma hepatocellular carcinoma with nodule‐in‐nodule appearance reverse transcription‐polymerase chain reaction
  26 in total

1.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Authors:  X R Xu; J Huang; Z G Xu; B Z Qian; Z D Zhu; Q Yan; T Cai; X Zhang; H S Xiao; J Qu; F Liu; Q H Huang; Z H Cheng; N G Li; J J Du; W Hu; K T Shen; G Lu; G Fu; M Zhong; S H Xu; W Y Gu; W Huang; X T Zhao; G X Hu; J R Gu; Z Chen; Z G Han
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Enhancing the effect of secreted cyclophilin B on immunosuppressive activity of cyclosporine.

Authors:  A Denys; F Allain; E Masy; J P Dessaint; G Spik
Journal:  Transplantation       Date:  1998-04-27       Impact factor: 4.939

3.  Transducin-like enhancer of split proteins, the human homologs of Drosophila groucho, interact with hepatic nuclear factor 3beta.

Authors:  J C Wang; M Waltner-Law; K Yamada; H Osawa; S Stifani; D K Granner
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

5.  Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes.

Authors:  S Maas; A P Gerber; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Pathology of early hepatocellular carcinoma: progression from early to advanced.

Authors:  M Kojiro
Journal:  Hepatogastroenterology       Date:  1998-08

7.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.

Authors:  R Cao; H L Wu; N Veitonmäki; P Linden; J Farnebo; G Y Shi; Y Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins.

Authors:  O Nakashima; S Sugihara; M Kage; M Kojiro
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

10.  Genomic structure of the human NDUFS8 gene coding for the iron-sulfur TYKY subunit of the mitochondrial NADH:ubiquinone oxidoreductase.

Authors:  R de Sury; P Martinez; V Procaccio; J Lunardi; J P Issartel
Journal:  Gene       Date:  1998-07-17       Impact factor: 3.688

View more
  35 in total

1.  Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells.

Authors:  Insoo Suh; Julie Weng; Gustavo Fernandez-Ranvier; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Arch Surg       Date:  2010-03

2.  hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing.

Authors:  Chung-Fan Lee; Derick S-C Ou; Sung-Bau Lee; Liang-Hao Chang; Ruo-Kai Lin; Ying-Shiuan Li; Anup K Upadhyay; Xiaodong Cheng; Yi-Ching Wang; Han-Shui Hsu; Michael Hsiao; Cheng-Wen Wu; Li-Jung Juan
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

3.  Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).

Authors:  Y Xiong; S Wu; Q Du; A Wang; Z Wang
Journal:  Cancer Gene Ther       Date:  2015-10-02       Impact factor: 5.987

4.  Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.

Authors:  Simone M Brändle; Manuela Cerina; Susanne Weber; Kathrin Held; Amélie F Menke; Carmen Alcalá; David Gebert; Alexander M Herrmann; Hannah Pellkofer; Lisa Ann Gerdes; Stefan Bittner; Frank Leypoldt; Bianca Teegen; Lars Komorowski; Tania Kümpfel; Reinhard Hohlfeld; Sven G Meuth; Bonaventura Casanova; Nico Melzer; Eduardo Beltrán; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

5.  Composition and biological significance of the human Nalpha-terminal acetyltransferases.

Authors:  Kristian K Starheim; Darina Gromyko; Rolf Velde; Jan Erik Varhaug; Thomas Arnesen
Journal:  BMC Proc       Date:  2009-08-04

6.  NELF potentiates gene transcription in the Drosophila embryo.

Authors:  Xiaoling Wang; Saiyu Hang; Lisa Prazak; J Peter Gergen
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

7.  Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.

Authors:  Xiao Cui; Zhi-Ping Hu; Zhao Li; Peng-Ji Gao; Ji-Ye Zhu
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

8.  Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span.

Authors:  Arunangshu Das; James D Bortner; Cesar A Aliaga; Aaron Baker; Anne Stanley; Bruce A Stanley; Matthew Kaag; John P Richie; Karam El-Bayoumy
Journal:  Prostate       Date:  2012-08-21       Impact factor: 4.104

Review 9.  Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

Authors:  Yutaka Midorikawa; Masatoshi Makuuchi; Wei Tang; Hiroyuki Aburatani
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients.

Authors:  Yan Zeng; Caiyun Liu; Bin Dong; Yuanyuan Li; Beihai Jiang; Ye Xu; Lin Meng; Jian Wu; Like Qu; Chengchao Shou
Journal:  Med Oncol       Date:  2013-04-02       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.